* Affymetrix Inc., of Santa Clara, Calif., appointedKenneth Nussbacher as executive vice president and chieffinancial officer.
* Allelix Biopharmaceuticals Inc., of Toronto, appointedLinda Willis as vice president, finance, and chieffinancial officer.
* BioCryst Pharmaceuticals Inc., of Birmingham, Ala.,hired George Omura as vice president of clinicaldevelopment.
* Connective Therapeutics Inc., of Palo Alto, Calif.,appointed Richard Hammel to the new position of vicepresident, corporate development.
* Interneuron Pharmaceuticals Inc., of Lexington, Mass.,named Brian Anderson to the new position of senior vicepresident of marketing and commercial development.
* Mercator Genetics Inc., of Menlo Park, Calif.,appointed Elliott Sigal to the position of vice president ofresearch and investment.
* MicroGeneSys Inc., of Meriden, Conn., appointedDaniel Adams as CEO.
* NaPro BioTherapeutics Inc., of Boulder, Colo.,appointed David Denny as vice president, operations.
* SciClone Pharmaceuticals Inc., of San Mateo, Calif.,promoted Shawn Singh to the position of vice president,business development.
* Therexsys Ltd., of Staffordshire, England, appointedMartin Preuveneers as chief executive officer. Mostrecently he was director of business development,Europe, for Glaxo Wellcome plc, of London.
(c) 1997 American Health Consultants. All rights reserved.